Tolerance of Healthy, Term Infants to Infant Formulas
1 other identifier
interventional
180
1 country
10
Brief Summary
To assess the gastrointestinal tolerance of healthy full-term infants fed either experimental formula or a control formula
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 healthy
Started Sep 2007
Shorter than P25 for phase_2 healthy
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
October 5, 2007
CompletedFirst Posted
Study publicly available on registry
October 15, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedJuly 4, 2008
June 1, 2008
8 months
October 5, 2007
July 3, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean rank stool consistency (MRSC)
Study Day 1 to Visit 3
Secondary Outcomes (1)
MRSC, percent watery stools, average number of stools per day, percent of feedings with spit-up and/or vomiting
4 months
Study Arms (4)
Milk based formula A
EXPERIMENTALExperimental milk based infant formula
Standard formula
ACTIVE COMPARATORstandard milk based infant formula
Reference
OTHERHuman milk
Milk based formula C
EXPERIMENTALExperimental milk based infant formula
Interventions
Eligibility Criteria
You may qualify if:
- judged to be in good health.
- singleton from a full term birth with a gestational age of 37-42 weeks
- birth weight was \> 2490 g (\~5 lbs 8 oz)
- between 0 and 8 days of age at enrollment.
- Infant's parent(s) or a LAR has voluntarily signed and dated an ICF, approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study.
You may not qualify if:
- An adverse maternal, fetal or infant medical history thought by the investigator to have potential for effects on tolerance, growth, and/or development, including, but not limited to suspected maternal substance abuse.
- Infant has been treated with antibiotics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (10)
The Pediatric Clinic
North Little Rock, Arkansas, 72117, United States
USF
Tampa, Florida, 33606, United States
North Georgia Clinical Research, White's Pediatrics
Dalton, Georgia, 30721, United States
Medical Associates Clinic
Dubuque, Iowa, 52001, United States
Midwest Children's Health Research Institute, LLC
Lincoln, Nebraska, 68505, United States
The Childrens Medical Group LLC
Poughkeepsie, New York, 12603, United States
Levine Childrens Hospital
Charlotte, North Carolina, 28207, United States
Ohio Pediatrics, Inc.
Huber Heights, Ohio, 45424, United States
Institute of Clinical Research
Mayfield Heights, Ohio, 44124, United States
Scott & White Memorial Hospital
Temple, Texas, 78508, United States
Related Publications (1)
Williams T, Choe Y, Price P, Katz G, Suarez F, Paule C, Mackey A. Tolerance of formulas containing prebiotics in healthy, term infants. J Pediatr Gastroenterol Nutr. 2014 Nov;59(5):653-8. doi: 10.1097/MPG.0000000000000513.
PMID: 25061716DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Timberly A. Williams, M.S.
Abbott Nutrition, Abbott Laboratories
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 5, 2007
First Posted
October 15, 2007
Study Start
September 1, 2007
Primary Completion
May 1, 2008
Study Completion
June 1, 2008
Last Updated
July 4, 2008
Record last verified: 2008-06